Anne Marie Finley of Biotech Policy Group to Present Patient Centric Value Model During Medidata NEXT – The Vanguard Healthcare Forum In New York

NEW YORK, NY, October 25 – Biotech Policy Group, an industry leading healthcare regulatory policy and government relations consulting firm will be featured at the Medidata NEXT – The Vanguard Healthcare Forum in New York on October 24th and 25th, 2018. Medidata NEXT – The Vanguard Healthcare Forum connects professionals in the Life Sciences to…

Anne Marie Finley of Biotech Policy Group to Present Moving Beyond Rare Diseases: What Are the Challenges? and Academia, Industry, & Venture Partnerships: The New Wave During Genetic RX Conference at Harvard Medical School

BOSTON, MA, December 7 – Biotech Policy Group, an industry leading healthcare regulatory policy and government relations consulting firm will be featured at the Genetic Rx Boston Conference at Harvard Medical School in Boston on December 7, 2017 to discuss the challenges in genetic therapy development for rare and more common diseases and a second…

Biotech Policy Group To Conclude Anti-Infectives Rx Conference at Harvard Medical School

BOSTON, MA, September 18 – Biotech Policy Group, an industry leading healthcare regulatory policy and government relations consulting firm will be featured at the Anti-Infectives Rx Conference at Harvard Medical School in Boston on September 19, 2017 to discuss the industry outlook over the next five years. Anti-Infectives Rx is an off-the- record networking forum…

Genetic Rx Conference to Feature Biotech Policy Group President Anne Marie Finley

Boston, MA, November 20th, 2015: Biotech Policy Group President Anne Marie Finley will speak at the Genetic Rx Conference at Harvard Medical School on December 3, 2015. Genetic Rx will take place at the Joseph B. Martin Conference Center at Harvard Medical School and will discuss the present and future of genetic therapies, pricing, reimbursement,…